<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03933644</url>
  </required_header>
  <id_info>
    <org_study_id>Zahnlos</org_study_id>
    <nct_id>NCT03933644</nct_id>
  </id_info>
  <brief_title>Comparison of the Ambu Aura GainTM With Gastric Tube Versus the Ambu Aura GainTM Without Gastric Tube in Endontolous Patient</brief_title>
  <official_title>Comparison of the Ambu Aura GainTM With Gastric Tube Versus the Ambu Aura GainTM Without Gastric Tube in Endontolous Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The AmbuÂ® Aura GainTM is a relatively new 2nd generation Supraglottic Airway Device (SGA)
      with a second port, providing gastric access to drain gastric content and air and it has an
      intergrated bite-block that helps avoiding rotation of the SGA.

      It has been described and it is known from daily routine, that SGA in edentulous patient
      provide inferior oropharyngeal leak pressure (OLP).

      The aim of the study is to evaluate if the placement of a gastric tube through the second
      orifice leads to better OLP and lowers the number of intervention needed for replacing the
      SGA.

      The study also evaluates the OLP after 15 minutes and after 30 minutes.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2019</start_date>
  <completion_date type="Anticipated">April 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal Leak Pressure</measure>
    <time_frame>immediately after insertion</time_frame>
    <description>after insertion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oropharyngeal Leak Pressure</measure>
    <time_frame>15 minutes</time_frame>
    <description>after 15 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oropharyngeal Leak Pressure</measure>
    <time_frame>30 minutes</time_frame>
    <description>after 30 minutes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Oropharyngeal Leak Pressure</condition>
  <arm_group>
    <arm_group_label>Ambu Aura Gain TM with gastric tube</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ambu Aura Gain TM without gastric tube</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Gastric Tube</intervention_name>
    <description>SGA is inserted with a gastric tube as guide for insertion</description>
    <arm_group_label>Ambu Aura Gain TM with gastric tube</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>No gastric Tube</intervention_name>
    <description>SGA is inserted without a gastric tube as guide for insertion</description>
    <arm_group_label>Ambu Aura Gain TM without gastric tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I - 3

          -  Signed informed consent

          -  Age 18 - 90 years

          -  Edentolous (or partial) patients

          -  Patients scheduled for elective surgery

        Exclusion Criteria:

          -  Patients with a known or predicted difficult airway

          -  Patients with anatomical disorders in the upper airway, the oesophagus or the trachea

          -  Patients at risk for aspiration

          -  Body mass index (BMI) &gt; 40 kg/m2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukas Gasteiger, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departement for Anaesthesia and Intensive Care - Medical University Innsbruck</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lukas Gasteiger, Dr</last_name>
    <phone>0043-512-504-22400</phone>
    <email>lukas.gasteiger@tirol-kliniken.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Corinna Velik-Salchner, PD Dr</last_name>
    <phone>0043-512-504-22400</phone>
  </overall_contact_backup>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 4, 2019</study_first_submitted>
  <study_first_submitted_qc>April 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2019</study_first_posted>
  <last_update_submitted>April 29, 2019</last_update_submitted>
  <last_update_submitted_qc>April 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

